Research analysts at StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP – Get Free Report) in a research report issued to clients and investors on Friday. The firm set a ...
Like many infectious diseases, tuberculosis was never eradicated, just suppressed – by a global public health effort that ...
The University of Oxford has commenced a new clinical trial called TB-45, which will test tuberculosis (TB) vaccine safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback